Compare OESX & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OESX | ELUT |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 42.5M |
| IPO Year | 2007 | 2020 |
| Metric | OESX | ELUT |
|---|---|---|
| Price | $9.92 | $0.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.50 | $6.00 |
| AVG Volume (30 Days) | 31.8K | ★ 53.3K |
| Earning Date | 02-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,306,000.00 | $12,293,000.00 |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $13.89 | $10.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.26 | N/A |
| 52 Week Low | $0.57 | $0.50 |
| 52 Week High | $18.64 | $2.50 |
| Indicator | OESX | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 34.85 |
| Support Level | $8.70 | $0.51 |
| Resistance Level | $11.49 | $1.00 |
| Average True Range (ATR) | 0.64 | 0.06 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 40.57 | 10.63 |
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.